MedTrace Logo

Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom

NCT04407156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 724

Last updated 2020-09-09

No results posted yet for this study

Summary

Severe Acute respiratory syndrome coronovirus (SARS-CoV-2) was first described in Wuhan in December 2019. It quickly spread to rest of the world and was declared pandemic by World health organisation. Initial case series focused on lung involvement in the form alveolar haemorrhages and respiratory failure. However, subsequently, there have been reports of kidney involvement resulting in severe acute kidney injury. However, the reported incidence from Chinese data has been less than 5% and detailed epidemiology of AKI in COVID-19 disease is lacking.

Conditions

Interventions

OTHER

acute kidney injury

AKI in COVID positive cases

Sponsors & Collaborators

  • University Hospitals of Derby and Burton NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Nitin V Kolhe, MD · University Hospitals of Derby and Burton

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-06-07
Completion
2020-07-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407156 on ClinicalTrials.gov